1- Chen, Y., Clarke, O. B., Kim, J., Stowe, S., Kim, Y. K., Assur, Z., Cavalier, M., Godoy-Ruiz, R., von Alpen, D. C., Manzini, C., Blaner, W. S., Frank, J., Quadro, L., Weber, D. J., Shapiro, L., Hendrickson, W. A., &Mancia, F. (2016). Structure of the STRA6 receptor for retinol uptake. Science (New York, N.Y.), 353(6302), aad8266. https://doi.org/10.1126/science.aad8266.
2- Kelly, Mary, and Johannes von Lintig. “STRA6: role in cellular retinol uptake and efflux.” Hepatobiliary surgery and nutrition vol. 4,4 (2015): 229-42. doi:10.3978/j.issn.2304-3881.2015.01.12
3- Barrett, Crisha et al. “Human Peripheral Blood Mononuclear Cells Express High Levels of the Vitamin a Transport Protein, Stimulated by Retinoic Acid 6 (P19-004-19).” Current Developments in Nutrition vol. 3,Suppl 1 nzz049.P19-004-19. 13 Jun. 2019, doi:10.1093/cdn/nzz049.P19-004-19
4- Developmental expression pattern of Stra6, a retinoic acid-responsive gene encoding a new type of membrane protein. Bouillet P, Sapin V, Chazaud C, Messaddeq N, Décimo D, Dollé P, Chambon P Mech Dev. 1997 May; 63(2):173-86.
5- Receptor-mediated cellular uptake mechanism that couples to intracellular storage.
Kawaguchi R, Yu J, Ter-Stepanian M, Zhong M, Cheng G, Yuan Q, Jin M, Travis GH, Ong D, Sun HACS Chem Biol. 2011 Oct 21; 6(10):1041-51.
6- RBP4 disrupts vitamin A uptake homeostasis in a STRA6-deficient animal model for Matthew-Wood syndrome. Isken A, Golczak M, Oberhauser V, Hunzelmann S, Driever W, Imanishi Y, Palczewski K, von Lintig J Cell Metab. 2008 Mar; 7(3):258-68.
.
7- Goodman DS. Vitamin A and retinoids in health and disease. N Engl J Med. 1984;310:1023–1031. doi: 10.1056/NEJM198404193101605.
8- Shirakami Y, Lee SA, Clugston RD, Blaner WS. Hepatic metabolism of retinoids and disease associations. BiochimBiophysActa. 2012;1821:124–136. doi: 10.1016/j.bbalip.2011.06.023.
9- Di Masi A, et al. Retinoic acid receptors: From molecular mechanisms to cancer therapy. Mol Aspects Med. 2015;41:1–115. doi: 10.1016/j.mam.2014.12.003.
10- West KP., Jr Extent of vitamin A deficiency among preschool children and women of reproductive age. J Nutr. 2002;132:2857S–2866S.
11. Czarnewski P., Das S., Parigi S.M., Villablanca E.J. Retinoic Acid and Its Role in Modulating Intestinal Innate Immunity. Nutrients. 2017;9:68. doi: 10.3390/nu9010068.
12. Cassani B., Villablanca E.J., De Calisto J., Wang S., Mora J.R. Vitamin A and immune regulation: Role of retinoic acid in gut-associated dendritic cell education, immune protection and tolerance. Mol. Asp. Med. 2012;33:63–76. doi: 10.1016/j.mam.2011.11.001.
13. Larange A., Cheroutre H. Retinoic Acid and Retinoic Acid Receptors as Pleiotropic Modulators of the Immune System. Annu. Rev. Immunol. 2016;34:369–394. doi: 10.1146/annurev-immunol-041015-055427.
14. Iwata M., Hirakiyama A., Eshima Y., Kagechika H., Kato C., Song S.-Y. Retinoic Acid Imprints Gut-Homing Specificity on T Cells. Immunity. 2004;21:527–538. doi: 10.1016/j.immuni.2004.08.011
15. Ross A.C. Vitamin A and retinoic acid in T cell–related immunity. Am. J. Clin. Nutr. 2012;96:1166S–1172S. doi: 10.3945/ajcn.112.034637.
16. Agace W. Generation of gut-homing T cells and their localization to the small intestinal mucosa. Immunol. Lett. 2010;128:21–23. doi: 10.1016/j.imlet.2009.09.012.
17. Sirisinha S. The pleiotropic role of vitamin A in regulating mucosal immunity. Asian Pac. J. Allergy Immunol. 2015;33:71–89.
18. Raverdeau M., Mills K. Modulation of T Cell and Innate Immune Responses by Retinoic Acid. J. Immunol. 2014;192:2953–2958. doi: 10.4049/jimmunol.1303245.
19. Guo Y., Brown C., Ortiz C., Noelle R.J. Leukocyte Homing, Fate, and Function Are Controlled by Retinoic Acid. Physiol. Rev. 2015;95:125–148. doi: 10.1152/physrev.00032.2013.
20. Hall J.A., Grainger J.R., Spencer S.P., Belkaid Y. The Role of Retinoic Acid in Tolerance and Immunity. Immunity. 2011;35:13–22. doi: 10.1016/j.immuni.2011.07.002.
21. Harrison E.H. Mechanisms of Digestion and Absorption of Dietary Vitamin A. Annu. Rev. Nutr. 2005;25:87–103. doi: 10.1146/annurev.nutr.25.050304.092614.
22. McDonald K.G., Leach M.R., Brooke K.W., Wang C., Wheeler L.W., Hanly E.K., Rowley C.W., Levin M.S., Wagner M., Li E., et al. Epithelial Expression of the Cytosolic Retinoid Chaperone Cellular Retinol Binding Protein II Is Essential for in Vivo Imprinting of Local Gut Dendritic Cells by Lumenal Retinoids. Am. J. Pathol. 2012;180:984–997. doi: 10.1016/j.ajpath.2011.11.009.
23. Ruiter B., Patil S.U., Shreffler W.G. Vitamins A and D have antagonistic effects on expression of effector cytokines and gut-homing integrin in human innate lymphoid cells. Clin. Exp. Allergy. 2015;45:1214–1225. doi: 10.1111/cea.12568
24. Iwata M. Retinoic acid production by intestinal dendritic cells and its role in T-cell trafficking. Semin. Immunol. 2009;21:8–13. doi: 10.1016/j.smim.2008.09.002.
25. Mora J.R., Iwata M., Eksteen B., Song S.Y., Junt T., Senman B., Otipoby K.L., Yokota A., Takeuchi H., Ricciardi-Castagnoli P., et al. Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells. Science. 2006;314:1157–1160. doi: 10.1126/science.1132742.
26. Reis B.S., Rogoz A., Costa-Pinto F.A., Taniuchi I., Mucida D. Mutual expression of the transcription factors Runx3 and ThPOK regulates intestinal CD4(+) T cell immunity. Nat. Immunol. 2013;14:271–280. doi: 10.1038/ni.2518.
27. Iwata M., Yokota A. Retinoic Acid Production by Intestinal Dendritic Cells. Klotho. 2011;86:127–152. doi: 10.1016/b978-0-12-386960-9.00006-x.
28. Bhattacharya N., Yuan R., Prestwood T.R., Penny H.L., DiMaio M.A., Reticker-Flynn N., Krois C.R., Kenkel J.A., Pham T.D., Carmi Y., et al. Normalizing Microbiota-Induced Retinoic Acid Deficiency Stimulates Protective CD8 + T Cell-Mediated Immunity in Colorectal Cancer. Immunity. 2016;45:641–655. doi: 10.1016/j.immuni.2016.08.008.
29. Iliev I.D., Mileti E., Matteoli G., Chieppa M., Rescigno M. Intestinal epithelial cells promote colitis-protective regulatory T-cell differentiation through dendritic cell conditioning. Mucosal Immunol. 2009;2:340–350. doi: 10.1038/mi.2009.13.
30. Napoli J.L., Yoo H.S. Retinoid metabolism and functions mediated by retinoid binding-proteins. Methods Enzymol. 2020;637:55–75. doi: 10.1016/bs.mie.2020.02.004.
31. Villablanca E.J., Wang S., de Calisto J., Gomes D.C., Kane M.A., Napoli J.L., Blaner W.S., Kagechika H., Blomhoff R., Rosemblatt M., et al. MyD88 and retinoic acid signaling pathways interact to modulate gastrointestinal activities of dendritic cells. Gastroenterology. 2011;141:176–185. doi: 10.1053/j.gastro.2011.04.010.
32. Liu Z.-M., Wang K.-P., Ma J., Zheng S.G. The role of all-trans retinoic acid in the biology of Foxp3+ regulatory T cells. Cell. Mol. Immunol. 2015;12:553–557. doi: 10.1038/cmi.2014.133.
33. Villablanca E.J. Retinoic acid-producing DCs and gut-tropic FOXP3+regulatory T cells in the induction of oral tolerance. OncoImmunology. 2013;2:e22987. doi: 10.4161/onci.22987.
34. Bono M.R., Tejon G., Flores-Santibañez F., Fernandez D., Rosemblatt M., Sauma D. Retinoic Acid as a Modulator of T Cell Immunity. Nutrients. 2016;8:349. doi: 10.3390/nu8060349.
35. Spencer S.P., Wilhelm C., Yang Q., Hall J.A., Bouladoux N., Boyd A., Nutman T.B., Urban J.F., Wang J., Ramalingam T.R., et al. Adaptation of Innate Lymphoid Cells to a Micronutrient Deficiency Promotes Type 2 Barrier Immunity. Science. 2014;343:432–437. doi: 10.1126/science.1247606. [
36. Mielke L.A., Jones S.A., Raverdeau M., Higgs R., Stefanska A., Groom J.R., Misiak A., Dungan L.S., Sutton C.E., Streubel G., et al. Retinoic acid expression associates with enhanced IL-22 production by gammadelta T cells and innate lymphoid cells and attenuation of intestinal inflammation. J. Exp. Med. 2013;210:1117–1124. doi: 10.1084/jem.20121588.
37. Bernink J.H., Krabbendam L., Germar K., de Jong E., Gronke K., Kofoed-Nielsen M., Munneke J.M., Hazenberg M.D., Villaudy J., Buskens C.J., et al. Interleukin-12 and -23 Control Plasticity of CD127+ Group 1 and Group 3 Innate Lymphoid Cells in the Intestinal Lamina Propria. Immunity. 2015;43:146–160. doi: 10.1016/j.immuni.2015.06.019.
38. Auci D.L., Egilmez N.K. Synergy of Transforming Growth Factor Beta 1 and All Trans Retinoic Acid in the Treatment of Inflammatory Bowel Disease: Role of Regulatory T cells. J. Gastroenterol. Pancreatol. Liver Disord. 2016;3 doi: 10.15226/2374-815X/3/4/00166.
39. Penny H.L., Prestwood T.R., Bhattacharya N., Sun F., Kenkel J.A., Davidson M.G., Shen L., Zuniga L.A., Seeley E.S., Pai R., et al. Restoring Retinoic Acid Attenuates Intestinal Inflammation and Tumorigenesis in APCMin/+ Mice. Cancer Immunol. Res. 2016;4:917–926. doi: 10.1158/2326-6066.CIR-15-0038. [
40 Keino H., Watanabe T., Sato Y., Okada A.A. Anti-inflammatory effect of retinoic acid on experimental autoimmune uveoretinitis. Br. J. Ophthalmol. 2010;94:802–807. doi: 10.1136/bjo.2009.171314.
41. Jijon H.B., Suarez-Lopez L., Diaz O.E., Das S., De Calisto J., Yaffe M.B., Pittet M.J., Mora J.R., Belkaid Y., Xavier R.J., et al. Intestinal epithelial cell-specific RARalpha depletion results in aberrant epithelial cell homeostasis and un-derdeveloped immune system. Mucosal Immunol. 2018;11:703–715. doi: 10.1038/mi.2017.91]
42. Klebanoff C.A., Spencer S.P., Torabi-Parizi P., Grainger J.R., Roychoudhuri R., Ji Y., Sukumar M., Muranski P., Scott C.D., Hall J.A., et al. Retinoic acid controls the homeostasis of pre-cDC-derived splenic and intestinal dendritic cells. J. Exp. Med. 2013;210:1961–1976. doi: 10.1084/jem.20122508.
43. Erkelens M.N., Mebius R.E. Retinoic Acid and Immune Homeostasis: A Balancing Act. Trends Immunol. 2017;38:168–180. doi: 10.1016/j.it.2016.12.006.
44. Klatt N.R., Estes J.D., Sun X., Ortiz A.M., Barber J.S., Harris L.D., Cervasi B., Yokomizo L.K., Pan L., Vinton C.L., et al. Loss of mucosal CD103+ DCs and IL-17+ and IL-22+ lymphocytes is associated with mucosal damage in SIV infection. Mucosal Immunol. 2012;5:646–657. doi: 10.1038/mi.2012.38.
45. Huang W., Yu J., Liu T., Tudor G., Defnet A.E., Zalesak S., Kumar P., Booth C., Farese A.M., MacVittie T.J., et al. Proteomic Evaluation of the Natural History of the Acute Radiation Syndrome of the Gastrointestinal Tract in a Non-human Primate Model of Partial-body Irradiation with Minimal Bone Marrow Sparing Includes Dysregulation of the Retinoid Pathway. Health Phys. 2020;119:604–620. doi: 10.1097/HP.0000000000001351.
46. Magnusson M., Brynjolfsson S., Dige A., Uronen-Hansson H., Börjesson L.G., Bengtsson J.L., Gudjonsson S., Ohman L., Agnholt J., Sjovall H., et al. Macrophage and dendritic cell subsets in IBD: ALDH+ cells are reduced in colon tissue of patients with ulcerative colitis regardless of inflammation. Mucosal Immunol. 2016;9:171–182. doi: 10.1038/mi.2015.48.
47. Collins C.B., Aherne C.M., Kominsky D., McNamee E.N., Lebsack M.D., Eltzschig H., Jedlicka P., Rivera–Nieves J. Retinoic Acid Attenuates Ileitis by Restoring the Balance Between T-Helper 17 and T Regulatory Cells. Gastroenterology. 2011;141:1821–1831. doi: 10.1053/j.gastro.2011.05.049.
48. Coombes J.L., Siddiqui K.R., Arancibia-Carcamo C.V., Hall J., Sun C.M., Belkaid Y., Powrie F. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J. Exp. Med. 2007;204:1757–1764. doi: 10.1084/jem.20070590.
49. Sun C.-M., Hall J.A., Blank R.B., Bouladoux N., Oukka M., Mora J.R., Belkaid Y. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 2007;204:1775–1785. doi: 10.1084/jem.20070602.
50. Mucida D., Park Y., Kim G., Turovskaya O., Scott I., Kronenberg M., Cheroutre H. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science. 2007;317:256–260. doi: 10.1126/science.1145697.
51. Xiao S., Jin H., Korn T., Liu S.M., Oukka M., Lim B., Kuchroo V.K. Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. J. Immunol. 2008;181:2277–2284. doi: 10.4049/jimmunol.181.4.2277.
52. Elias K.M., Laurence A., Davidson T.S., Stephens G., Kanno Y., Shevach E.M., O’Shea J.J. Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independ-ent signaling pathway. Blood. 2008;111:1013–1020. doi: 10.1182/blood-2007-06-096438
53. Strauch U.G., Grunwald N., Obermeier F., Gürster S., Rath H.C. Loss of CD103+ intestinal dendritic cells during colonic inflammation. World J. Gastroenterol. 2010;16:21–29. doi: 10.3748/wjg.v16.i1.21.
54. Laffont S., Siddiqui K.R., Powrie F. Intestinal inflammation abrogates the tolerogenic properties of MLN CD103+ dendritic cells. Eur. J. Immunol. 2010;40:1877–1883. doi: 10.1002/eji.200939957.
55. Brown C.C., Esterhazy D., Sarde A., London M., Pullabhatla V., Osma-Garcia I., Al-Bader R., Ortiz C., Elgueta R., Arno M., et al. Retinoic Acid Is Essential for Th1 Cell Lineage Stability and Prevents Transition to a Th17 Cell Program. Immunity. 2015;42:499–511. doi: 10.1016/j.immuni.2015.02.003.
56. Tejon G.P., Manríquez V., De Calisto J., Flores-Santibañez F., Hidalgo Y., Crisóstomo N., Fernandez D., Sauma D., Mora J.R., Bono M.R., et al. Vitamin A Impairs the Reprogramming of Tregs into IL-17-Producing Cells during Intestinal Inflammation. BioMed Res. Int. 2015;2015:1–8. doi: 10.1155/2015/137893.
57. Kim C.H. Control of Innate and Adaptive Lymphocytes by the RAR-Retinoic Acid Axis. Immune Netw. 2018;18:e1. doi: 10.4110/in.2018.18.e1
58. Alter G., Teigen N., Davis B.T., Addo M., Suscovich T.J., Waring M.T., Streeck H., Johnston M.N., Staller K., Zaman M.T., et al. Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection. Blood. 2005;106:3366–3369. doi: 10.1182/blood-2005-03-1100.
59. Alter G., Heckerman D., Schneidewind A., Fadda L., Kadie C.M., Carlson J.M., Oniangue-Ndza C., Martin M., Li B., Khakoo S., et al. HIV-1 adaptation to NK-cell-mediated immune pressure. Nature. 2011;476:96–100. doi: 10.1038/nature10237.
60. O’Connor G.M., Holmes A., Mulcahy F., Gardiner C.M. Natural killer cells from long-term non-progressor HIV patients are characterized by altered pheno-type and function. Clin. Immunol. 2007;124:277–283. doi: 10.1016/j.clim.2007.05.016.
61. Fehniger T., Herbein G., Yu H., Para M.I., Bernstein Z.P., O’Brien W.A., Caligiuri M.A. Natural killer cells from HIV-1+ patients produce C-C chemokines and inhibit HIV-1 infection. J. Immunol. 1998;161:6433–6438.
62. Shieh T.M., Carter D.L., Blosser R.L., Mankowski J.L., Zink M.C., Clements J.E. Functional analyses of natural killer cells in macaques infected with neurovirulent simian immunodeficiency virus. J. Neurovirol. 2001;7:11–24.
63. Vowels B.R., Gershwin M.E., Gardner M.B., McGRAW T.P. Natural Killer Cell Activity of Rhesus Macaques Against Retrovirus-Pulsed CD4+ Target Cells. AIDS Res. Hum. Retrovir. 1990;6:905–918. doi: 10.1089/aid.1990.6.905.
64. Giavedoni L.D., Velasquillo M.C., Parodi L.M., Hubbard G.B., Hodara V.L. Cytokine Expression, Natural Killer Cell Activation, and Phenotypic Changes in Lymphoid Cells from Rhesus Macaques during Acute Infection with Pathogenic Simian Immunodeficiency Virus. J. Virol. 2000;74:1648–1657. doi: 10.1128/JVI.74.4.1648-1657.2000.
65. Pereira L., Johnson R., Ansari A. Sooty mangabeys and rhesus macaques exhibit significant divergent natural killer cell responses during both acute and chronic phases of SIV infection. Cell. Immunol. 2008;254:10–19. doi: 10.1016/j.cellimm.2008.06.006.
66. Bostik P., Kobkitjaroen J., Tang W., Villinger F., Pereira L.E., Little D.M., Stephenson S.T., Bouzyk M., Ansari A.A. Decreased NK Cell Frequency and Function Is Associated with Increased Risk of KIR3DL Allele Polymorphism in Simian Immunodeficiency Virus-Infected Rhesus Macaques with High Viral Loads. J. Immunol. 2009;182:3638–3649. doi: 10.4049/jimmunol.0803580.
67. Takahashi Y., Byrareddy S.N., Albrecht C., Brameier M., Walter L., Mayne A.E., Dunbar R., Russo R., Little D.M., Villinger T., et al. In Vivo Administration of a JAK3 Inhibitor during Acute SIV Infection Leads to Significant Increases in Viral Load during Chronic Infection. PLOS Pathog. 2014;10:e1003929. doi: 10.1371/journal.ppat.1003929
68. DeGottardi M.Q., Okoye A.A., Vaidya M., Talla A., Konfe A.L., Reyes M.D., Clock J.A., Duell D.M., Legasse A.W., Sabnis A., et al. Effect of Anti–IL-15 Administration on T Cell and NK Cell Homeostasis in Rhesus Macaques. J. Immunol. 2016;197:1183–1198. doi: 10.4049/jimmunol.1600065.
69. Strauss-Albee D.M., Fukuyama J., Liang E.C., Yao Y., Jarrell J.A., Drake A.L., Kinuthia J., Montgomery R.R., John-Stewart G., Holmes S., et al. Human NK cell repertoire diversity reflects immune experience and correlates with viral suscepti-bility. Sci. Transl. Med. 2015;7:297ra115. doi: 10.1126/scitranslmed.aac5722.
70. Byrareddy S.N., Arthos J., Cicala C., Villinger F., Ortiz K.T., Little D., Sidell N., Kane M.A., Yu J., Jones J.W., et al. Sustained virologic control in SIV+ macaques after antiretroviral and alpha4beta7 antibody therapy. Science. 2016;354:197–202. doi: 10.1126/science.aag1276.
71. Cella M., Fuchs A., Vermi W., Facchetti F., Otero K., Lennerz J.K.M., Doherty J.M., Mills J.C., Colonna M. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature. 2008;457:722–725. doi: 10.1038/nature07537.
72. Takatori H., Kanno Y., Watford W.T., Tato C.M., Weiss G., Ivanov I.I., Littman D.R., O’Shea J.J. Lymphoid tissue inducer–like cells are an innate source of IL-17 and IL-22. J. Exp. Med. 2008;206:35–41. doi: 10.1084/jem.20072713.
73. Spits H., Artis D., Colonna M., Diefenbach A., Di Santo J.P., Eberl G., Koyasu S., Locksley R.M., McKenzie A.N.J., Mebius R.E., et al. Innate lymphoid cells—A proposal for uniform nomenclature. Nat. Rev. Immunol. 2013;13:145–149. doi: 10.1038/nri3365. [PubMed] [CrossRef] [Google Scholar]
74. Hoyler T., Klose C.S., Souabni A., Turqueti-Neves A., Pfeifer D., Rawlins E.L., Voehringer D., Busslinger M., Diefenbach A. The Transcription Factor GATA-3 Controls Cell Fate and Maintenance of Type 2 Innate Lymphoid Cells. Immunity. 2012;37:634–648. doi: 10.1016/j.immuni.2012.06.020.
75. Mjösberg J., Bernink J., Golebski K., Karrich J.J., Peters C.P., Blom B., Velde A.A.T., Fokkens W.J., van Drunen C.M., Spits H. The Transcription Factor GATA3 Is Essential for the Function of Human Type 2 Innate Lymphoid Cells. Immunity. 2012;37:649–659. doi: 10.1016/j.immuni.2012.08.015.
76. Goverse G., Labao-Almeida C., Ferreira M., Molenaar R., Wahlen S., Konijn T., Koning J., Veiga-Fernandes H., Mebius R.E. Vitamin A Controls the Presence of RORgamma+ Innate Lymphoid Cells and Lymphoid Tissue in the Small Intestine. J. Immunol. 2016;196:5148–5155. doi: 10.4049/jimmunol.1501106.
77. Van de Pavert S.A., Ferreira M., Domingues R.G., Ribeiro H., Molenaar R., Moreira-Santos L., Almeida F.F., Ibiza S., Barbosa I., Goverse G., et al. Maternal retinoids control type 3 innate lymphoid cells and set the offspring immunity. Nature. 2014;508:123–127. doi: 10.1038/nature13158.
78. Reeves R.K., Rajakumar P.A., Evans T.I., Connole M., Gillis J., Wong F.E., Kuzmichev Y.V., Carville A., Johnson R.P. Gut inflammation and indoleamine deoxygenase inhibit IL-17 production and promote cytotoxic potential in NKp44+ mucosal NK cells during SIV infection. Blood. 2011;118:3321–3330. doi: 10.1182/blood-2011-04-347260.
79. Xu H., Wang X., Liu D.X., Moroney-Rasmussen T., Lackner A.A., Veazey R.S. IL-17-producing innate lymphoid cells are restricted to mucosal tissues and are depleted in SIV-infected macaques. Mucosal Immunol. 2012;5:658–669. doi: 10.1038/mi.2012.39.
80. Khowawisetsut L., Pattanapanyasat K., Onlamoon N., Mayne A.E., Little D.M., Villinger F., Ansari A.A. Relationships between IL-17+ Subsets, Tregs and pDCs That Distinguish among SIV Infected Elite Controllers, Low, Medium and High Viral Load Rhesus Macaques. PLoS ONE. 2013;8:e61264. doi: 10.1371/journal.pone.0061264. [
81. Liyanage N.P., Gordon S.N., Doster M.N., Pegu P., Vaccari M., Shukur N., Schifanella L., Pise-Masison C.A., Lipinska D., Grubczak K., et al. Antiretroviral therapy partly reverses the systemic and mucosal distribution of NK cell subsets that is altered by SIVmac251 infection of macaques. Virology. 2014;450–451:359–368. doi: 10.1016/j.virol.2013.12.003
82. Li H., Richert-Spuhler L.E., Evans T.I., Gillis J., Connole M., Estes J.D., Keele B.F., Klatt N.R., Reeves R.K. Hypercytotoxicity and Rapid Loss of NKp44+ Innate Lymphoid Cells during Acute SIV Infection. PLoS Pathog. 2014;10:e1004551. doi: 10.1371/journal.ppat.1004551.
83. Li H., Reeves R.K. Functional perturbation of classical natural killer and innate lymphoid cells in the oral mucosa during SIV infection. Front. Immunol. 2013;3:417. doi: 10.3389/fimmu.2012.00417.
84. Spits H., Di Santo J.P. The expanding family of innate lymphoid cells: Regulators and effectors of immunity and tissue remodeling. Nat. Immunol. 2011;12:21–27. doi: 10.1038/ni.1962
85. Satoh-Takayama N., Vosshenrich C.A.J., Lesjean-Pottier S., Sawa S., Lochner M., Rattis F., Mention J.-J., Thiam K., Cerf-Bensussan N., Mandelboim O., et al. Microbial Flora Drives Interleukin 22 Production in Intestinal NKp46+ Cells that Provide Innate Mucosal Immune Defense. Immunity. 2008;29:958–970. doi: 10.1016/j.immuni.2008.11.001.
86. Sonnenberg G.F., Monticelli L.A., Elloso M.M., Fouser L.A., Artis D. CD4+ Lymphoid Tissue-Inducer Cells Promote Innate Immunity in the Gut. Immunity. 2011;34:122–134. doi: 10.1016/j.immuni.2010.12.009.
87. Zheng Y., Valdez P.A., Danilenko D.M., Hu Y., Sa S.M., Gong Q., Abbas A.R., Modrusan Z., Ghilardi N., De Sauvage F.J., et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat. Med. 2008;14:282–289. doi: 10.1038/nm1720.
88-Barrett C, Fantin H, Smiles B, Duriancik D. Human Peripheral Blood Mononuclear Cells Express High Levels of the Vitamin a Transport Protein, Stimulated by Retinoic Acid 6 (P19-004-19). Curr Dev Nutr. 2019 Jun 13;3(Suppl 1):nzz049.P19-004-19. doi: 10.1093/cdn/nzz049.P19-004-19. PMCID: PMC6574971.
89-Ross AC. Vitamin A and retinoic acid in T cell-related immunity. Am J Clin Nutr. 2012 Nov;96(5):1166S-72S. doi: 10.3945/ajcn.112.034637. Epub 2012 Oct 10. PMID: 23053562; PMCID: PMC3471201.
90-Iwata, M.; Hirakiyama, A.; Eshima, Y.; Kagechika, H.; Kato, C.; Song, S.Y. Retinoic acid imprints gut-homing specificity on T cells. Immunity 2004, 21, 527–538.
91- Svensson, M.; Johansson-Lindbom, B.; Zapata, F.; Jaensson, E.; Austenaa, L.M.; Blomhoff, R.; Agace, W.W. Retinoic acid receptor signaling levels and antigen dose regulate gut homing receptor expression on CD8+ T cells. Mucosal. Immunol. 2008, 1, 38–48.
92-Mora, J.R.; Iwata, M.; Eksteen, B.; Song, S.Y.; Junt, T.; Senman, B.; Otipoby, K.L.; Yokota, A.; Takeuchi, H.; Ricciardi-Castagnoli, P.; et al. Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells. Science 2006, 314, 1157–1160.
93-Mora, J.R.; von Andrian, U.H. Role of retinoic acid in the imprinting of gut-homing IgA-secreting cells. Semin. Immunol. 2009, 21, 28–35.
94-Walker B, McMichael A. The T-cell response to HIV. Cold Spring Harb Perspect Med. 2012 Nov 1;2(11):a007054. doi: 10.1101/cshperspect.a007054. PMID: 23002014; PMCID: PMC3543107.
95- Al Tanoury Z, Piskunov A, Rochette-Egly C. Vitamin A and retinoid signaling: Genomic and nongenomic effects. J Lipid Res. 2013;54:1761–1775. doi: 10.1194/jlr.R030833.
96- Goodman DS. Vitamin A and retinoids in health and disease. N Engl J Med. 1984;310:1023–1031. doi: 10.1056/NEJM198404193101605.
97- Shirakami Y, Lee SA, Clugston RD, Blaner WS. Hepatic metabolism of retinoids and disease associations. BiochimBiophysActa. 2012;1821:124–136. doi: 10.1016/j.bbalip.2011.06.023.
98- Di Masi A, et al. Retinoic acid receptors: From molecular mechanisms to cancer therapy. Mol Aspects Med. 2015;41:1–115. doi: 10.1016/j.mam.2014.12.003.
99- West KP., Jr Extent of vitamin A deficiency among preschool children and women of reproductive age. J Nutr. 2002;132:2857S–2866S.W
100- Elkazzaz M, Ahmed A, Abo-Amer YE, Hydara T, Haikal A, Razek DNAE, Eltayb WA, Wang X, Karpiński TM, Hamza D, Jabbar B, Shamkh IM. In Silico Discovery of GPCRs and GnRHRs as Novel Binding Receptors of SARS-CoV-2 Spike Protein Could Explain Neuroendocrine Disorders in COVID-19. Vaccines (Basel). 2022 Sep 8;10(9):1500. doi: 10.3390/vaccines10091500. PMID: 36146578; PMCID: PMC9504287.
101- Drain, P. K., R. Kupka, F. Mugusi, and W. W. Fawzi (2007). Micronutrients in HIV-positive persons receiving highly active antiretroviral therapy. American Journal of Clinical Nutrition, 85(2), 333–45